8 PRNewswireFirstCall DigitalFX International Inc

An additionalstudy is being conducted in patients with chronic back pain who may haveperfusion defects to their spine. For more information about CardioVascularBioTherapeutics, Inc. please visit http:// Media Contact: Allison Caplan, CardioVascular BioTherapeutics, Inc. (702) 839-7200, Investor Contact: Amy Montano Gordon, CardioVascular BioTherapeutics, Inc.

(702) 839-7220, SOURCECardioVascular BioTherapeutics, Inc.Media, Allison Caplan, 1-702-839-7200, , or Investors, AmyMontano Gordon, 1-702-839-7220, , both ofCardioVascular BioTherapeutics, Inc.. LAS VEGAS, Jan. 8 /PRNewswire-FirstCall/ DigitalFX International, Inc.(Amex: DXN), a multi-tier Web 2.0 digital media products distribution companyannounced today that the Company recently completed several transactions whichresulted in an additional cash investment of $2.0 million by its new Chairmanof the Board and CEO, Richard Kall, the restructuring of its Amended andRestated Senior Secured Convertible Notes ("the Existing Notes"), andtheauthorization and issuance of a new class of preferred stock, as part of theCompany's strategic plan to strengthen its financial position and capitalstructure Mr. With our upcoming newtechnology, our second-to-none compensation plan and unparalleled businessopportunity, we are positioning ourselves to be a true leader in the networkmarketing industry.

The world economics being what it is today, ouropportunity gives the average person a chance to be in big business withoutthe big business headaches. 'To be able to be in business for yourself, butnot by yourself'- that is what we are all about." Mr Kall continued.The $2.0 million investment by Mr Kall was finalized on December 22, 2008.Mr. Kall agreed to purchase from the Company 2,000,000 shares of Series APreferred Stock with 50 warrant coverage in exchange for $2.0 million incash Mr. Kall paid the aggregate purchase price to the Company through anadvance on November 14, 2008 of $500,000, an advance on December 18, 2008 of$200,000, and a cash payment of $1.3 million on December 22, 2008. "Our decision to raise the necessary funding from our existing majorityinvestor instead of the financial markets comes from our confidence that wewill be successful in executing on our growth strategy that will position usfavorably in the huge and growing global multi-tier marketplace, and suchgrowth should be reflected in our stock pricing," said Abraham Sofer, therecently elected President of the Company. "Improving profitability and ourstock value are keys to delivering our long-term growth objective and ourcompliance with American Stock Exchange rules. We remain committed togenerating value to our shareholders," added Sofer.In addition, on December 22, 2008, the Company entered into an Amendment andExchange Agreement with each of the institutional investors ("Investors")holding Existing Notes, subject to certain listing requirements and conditionsas fully described in the Company's Form 8-K filed December 23, 2008.Specifically, the Investors agreed to exchange their Existing Notes for acombination of (1) a cash payment of $650,000 (2) 5,520,000 shares of theCompany's common stock of WoozyFly Inc.